The report on the global retinal biologics market provides qualitative and quantitative analysis for the period from 2021-2030. The retinal biologics market was valued at USD 20.13 billion in 2022 and is expected to reach USD 47.11 billion in 2030, with a CAGR of 11.20% during the forecast period. The study on retinal biologics market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.
The report on retinal biologics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global retinal biologics market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global retinal biologics market over the period of 2021-2030. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
2. Complete coverage of all the segments in the retinal biologics market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global retinal biologics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
The report on retinal biologics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global retinal biologics market over the period of 2021-2030. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global retinal biologics market over the period of 2021-2030. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Report Findings
1) Drivers
- The rising prevalence of retinal diseases is propelling the growth of the market.
- The aging global population serves as a significant driver for the retinal biologics market.
2) Restraints
- Stringent regulatory processes, high development costs, and limited reimbursement policies may hinder the market's growth.
3) Opportunities
- Advancements in biotechnology and the increasing prevalence of retinal disorders create a lucrative opportunity for market growth.
Research Methodology
A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry
The primary research respondents typically include
1. Executives working with leading companies in the market under review2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.The secondary sources of the data typically include
1. Company reports and publications2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
Segment Covered
The global retinal biologics market is segmented on the basis of drug class, indication, and distribution channel.The Global Retinal Biologics Market by Drug Class
- TNF-alpha Inhibitor
- VEGF-A Antagonist
The Global Retinal Biologics Market by Indication
- Macular Degeneration
- Diabetic Retinopathy
- Uveitis
The Global Retinal Biologics Market by Distribution Channel
- Hospitals
- Clinics
- Pharmacies
Company Profiles
The companies covered in the report include
- Regeneron Pharmaceuticals, Inc.
- F. Hoffmann-La Roche Ltd
- AbbVie Inc.
- Amgen Inc.
- MeiraGTx Limited
- Novartis AG
- Coherus BioSciences, Inc.
- Oxurion NV
- Bayer AG
- Spark Therapeutics, Inc.
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the retinal biologics market.2. Complete coverage of all the segments in the retinal biologics market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global retinal biologics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Global Retinal Biologics Market Overview
Chapter 5. Company Profiles and Competitive Landscape
Chapter 6. Global Retinal Biologics Market by Drug Class
Chapter 7. Global Retinal Biologics Market by Indication
Chapter 8. Global Retinal Biologics Market by Distribution Channel
Chapter 9. Global Retinal Biologics Market by Region 2023-2030
Companies Mentioned
- Regeneron Pharmaceuticals, Inc.
- F. Hoffmann-La Roche Ltd
- AbbVie Inc.
- Amgen Inc.
- MeiraGTx Limited
- Novartis AG
- Coherus BioSciences, Inc.
- Oxurion NV
- Bayer AG
- Spark Therapeutics, Inc.
